ClinConnect ClinConnect Logo
Search / Trial NCT05214937

A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors

Launched by UNIVERSITY OF TORONTO · Jan 17, 2022

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Distance Based Sedentary Behavior Physical Activity Cancer Survivorship

ClinConnect Summary

This clinical trial is studying a 12-week program designed to help prostate cancer survivors become less sedentary, meaning they will spend less time sitting and more time being active. Participants in the trial will be divided into two groups: one group will receive a FitBit fitness tracker along with six support sessions from a movement specialist to encourage healthier habits, while the other group will only get the FitBit and access to general health resources. The goal is to see if the program can significantly reduce the amount of time participants spend being inactive, both right after the program and six months later.

To be eligible for this trial, participants must be at least 18 years old, diagnosed with specific types of prostate cancer, and not currently receiving radiation or chemotherapy. They should also be spending more than eight hours a day sitting and not meeting recommended physical activity levels. Participants will need access to a smartphone or computer and should be capable of participating without any serious medical conditions that affect their ability to walk. If you or a loved one meets these criteria, this trial may offer a supportive way to improve health and well-being after prostate cancer treatment.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • \>= 18 years of age
  • Diagnosed with localized or asymptomatic metastatic primary prostate cancer
  • Not currently undergoing radiation or chemotherapy
  • Proficient in English
  • Not physically active (self report \<150 minutes of moderate-to-vigorous physical activity per week)
  • Self-report \>8 hours of daily sedentary behaviour
  • In the contemplation or preparation stage for motivational readiness to change as determined by the Stages of Change Questionnaire
  • Access to a smartphone, tablet, or computer
  • No cardiac contraindications (e.g., unstable angina, arrhythmia, heart failure, aortic stenosis)
  • Medical clearance from a primary health care provider (if necessary)
  • Currently residing in Canada
  • Exclusion Criteria:
  • Not planning to live in Canada for the next 12 months
  • A medical condition that prohibits walking (e.g., severe knee or hip arthritis)
  • Presence of other primary or recurrent invasive cancer (i.e., other than non-melanoma skin cancer)
  • Have had a prior fall within the last 12-months
  • Use a gait aid device

About University Of Toronto

The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Linda Trinh, PhD

Principal Investigator

University of Toronto

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials